Skip to main content

Thorne Healthtech, Inc.

THRNDelisted Oct 16, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001844280

Thorne Healthtech, Inc. was delisted on Oct 16, 2023; its insiders filed their last Form 4 on Oct 18, 2023; 59 institutions reported holding it in 13F filings for Q3 2023, worth $82.9M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
59
Q3 2023, +15 vs. previous quarter
13F value
$82.9M
Reported value at the end of Q3 2023
Superinvestors holding
0
At the end of Q3 2023

Superinvestors holding THRN, Q3 2023

Go to the superinvestors tab

No superinvestor reported holding THRN at the end of Q3 2023.

Latest insider trades

Open-market purchases and sales by Thorne Healthtech, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 24, 2022 (view filing)Mar 231 dayVarma Saloni S.DirectorPPurchase+9.22K$6.01+$55.4K+61.5%24.2K after
Sep 28, 2021 (view filing)Sep 271 dayWheeler ScottChief Financial OfficerPPurchase+2.00K$10.00+$20.0K+5.9%35.8K after

Top 10 13F holders, Q3 2023

The largest institutional positions in Thorne Healthtech, Inc. at the end of Q3 2023; share changes are against Q2 2023.

See all 59 holders
Institutions holding THRN in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Glazer Capital, LLC1,330,841$13.6M0.88%+1,330,841New
Vanguard Group Inc860,553$8.77M0.00%+12,678+1.5%Added
Gabelli Funds LLC835,961$8.52M0.07%+835,961New
BlackRock Inc.733,214$7.47M0.00%+71,659+10.8%Added
Beryl Capital Management LLC623,775$6.36M0.81%+623,775New
Alpine Associates Management Inc.611,300$6.23M0.33%+611,300New
Qube Research & Technologies Ltd325,145$3.31M0.01%+325,145New
Geode Capital Management, LLC314,864$3.21M0.00%+64,912+26.0%Added
Cresset Asset Management, LLC285,207$2.91M0.02%+2,004+0.7%Added
Goldman Sachs Group Inc270,851$2.76M0.00%+256,880+1,838.7%Added